Implications of Perioperative Polypharmacy in Adolescents Undergoing Bariatric Surgery: a Single-Center Experience.
Elaine F WilliamsJanelle D VaughnsEleanor R MackeyJane C MuretEvan P NadlerJohannes N van den AnkerPublished in: Obesity surgery (2021)
Adolescents seeking bariatric surgery may present with pre-existing psychiatric diagnoses for which they use chronic medications. To heighten awareness concerning perioperative polypharmacy in adolescents with extreme obesity, we conducted a retrospective review of patients undergoing laparoscopic sleeve gastrectomy between February 2010 and May 2017 at Children's National Health System (CNHS). A total of 167 adolescent patients had pre-existing psychiatric diagnoses which included depression (50%), anxiety (23%), ADHD (23%), and binge eating disorder (11%). Medications prescribed to treat these diagnoses included selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Additionally, all patients were given fentanyl, ondansetron, morphine, and acetaminophen perioperatively. Although no life threatening symptoms of drug-drug interactions (DDIs) were appreciated, the combined use of many different potent drugs in these patients warrants attention.
Keyphrases
- end stage renal disease
- young adults
- bariatric surgery
- patients undergoing
- ejection fraction
- chronic kidney disease
- newly diagnosed
- mental health
- weight loss
- prognostic factors
- physical activity
- peritoneal dialysis
- type diabetes
- working memory
- patient reported outcomes
- body mass index
- adipose tissue
- sleep quality
- quality improvement